Wanting Shi

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Rongjun Zou, Wanting Shi, Junxiong Qiu et al. · Cardiovascular Diabetology · 2022 · 125 citations · Full text

Medicine, Cardiology, Pharmacology +17

SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways

Li Ma, Rongjun Zou, Wanting Shi et al. · Theranostics · 2022 · 119 citations · Full text

Medicine, Cardiology, Pharmacology +17

Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke

Rongjun Zou, Dingwen Zhang, Lei Lv et al. · Journal of Translational Medicine · 2019 · 108 citations · Full text

Life Sciences, Bioinformatics, Cardiology +17

Adipocyte-derived ferroptotic signaling mitigates obesity

Xue Wang, Qian Wu, Ying Chen et al. · Cell Metabolism · 2024 · 63 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks

Wanting Shi, Rongjun Zou, Minglei Yang et al. · Frontiers in Physiology · 2019 · 42 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17